Ivermectin and Cancer Cell Mechanisms

Across hundreds of preclinical studies now, so in the

laboratory, when they expose, uh, human cancer

cells to ivermectin or

mebendazole or fenbendazole, it, uh, kills

those cancer cells with 12 mechanisms.

The main mechanisms is it literally induces

apoptosis or programmed cell death, um,

specifically in cancer cells, not healthy cells.

It cuts off angiogenesis, which is the blood

supply to tumors, so it literally stops that, that

tumor spread by cutting off the blood supply.

It, it inhibits, uh, the glycolysis in these

tumors, so they cannot take up sugar to help grow

anymore. It disrupts microtubules in cancer

cells, which is a cell scaffolding essential

for cancer cell division. Um, mebendazole does that

quite potently, and it also targets cancer stem

cells, which are the source of a lot of these

cancers that

literally spawn from these cancer stem cells that chemo doesn't get

rid of. Ivermectin targets those quite

potently, and it interferes with cancer cells'

signaling, which is how cancer cells kind of

communicate

to each other and to themselves to help grow.

And so you cut off that communication chain, and the

tumors are going to end up shrinking and the cancer cells dying.